As of August 2024, Oncolys BioPharma has a market cap of $85.26M. This makes Oncolys BioPharma the world's 22244th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $69.02M | -7.05% |
2023 | $74.26M | 7.59% |
2022 | $69.02M | -0.19% |
2021 | $69.15M | -64.87% |
2020 | $196.85M | -21.84% |
2019 | $251.85M | 85.98% |
2018 | $135.42M | 32.39% |
2017 | $102.29M | -27.62% |
2016 | $141.31M | 67.55% |
2015 | $84.34M | -17.22% |
2014 | $101.89M | -75.73% |
2013 | $419.75M | - |